Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The intensive statin therapy myth.

Michael Shechter1, Roy Beigel, Shlomi Matetzky

  • 1Heart Institute, Sheba Medical Center, Tel Hashomer, Israel. shechtes@netvision.net.il

The Israel Medical Association Journal : IMAJ
|November 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substantial early morbidity and incomplete left ventricular recovery in Takotsubo syndrome: A single-center cohort study.

International journal of cardiology·2026
Same author

Safety and Feasibility of a CT-Based Pathway for Left Atrial Appendage Assessment Prior to Inpatient Cardioversion: A Single-Center Experience.

Clinical cardiology·2026
Same author

Impact of routine urine sodium evaluation on diuretic practices in patients with acute heart failure.

ESC heart failure·2026
Same author

Residual perfusion defects after acute pulmonary embolism: Prevalence, determinants, and clinical impact.

The American journal of medicine·2026
Same author

Clinical Features and Outcomes of Acute Myocarditis in Patients with Swab-Confirmed Respiratory Viral Pathogens.

The Israel Medical Association journal : IMAJ·2026
Same author

Frailty Modifies the Prognostic Effect of Age Among Older Adults With Acute Coronary Syndrome.

Journal of the American Heart Association·2025

Intensive statin therapy significantly improves outcomes for coronary artery disease (CAD) patients. This approach is safe and helps more patients reach cholesterol goals, despite current underutilization in clinical practice.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Statins are crucial for treating and preventing coronary artery disease (CAD) and atherosclerosis.
  • Current statin therapy use in CAD patients remains suboptimal, ranging from 30-60% in major regions.
  • A significant gap exists between evidence supporting statins and their clinical implementation.

Purpose of the Study:

  • To evaluate the impact of intensive statin therapy on clinical outcomes in CAD patients.
  • To assess the safety and efficacy of high-dose statin regimens compared to placebo or standard doses.
  • To determine if intensive statin therapy aids in achieving National Cholesterol Education Program (NCEP) lipid goals.

Main Methods:

  • A Medline search was conducted for prospective, double-blind, randomized clinical trials up to June 2005.

Related Experiment Videos

  • Included trials evaluated intensive statin therapy (any dose >40 mg/daily) with at least a 1-year follow-up.
  • Eight relevant trials with follow-up periods of 12-60 months were identified.

    • Main Results:

    • Intensive statin therapy demonstrated significantly greater effectiveness compared to placebo or standard statin regimens.
    • The safety profile of intensive statin therapy was comparable to other regimens.
    • More patients receiving intensive statin therapy achieved NCEP low-density lipoprotein (LDL) goals.

    Conclusions:

    • Intensive statin therapy is a safe and effective strategy for managing CAD.
    • This approach facilitates achievement of LDL cholesterol targets in a larger proportion of patients.
    • Evidence supports increased utilization of intensive statin therapy for improved CAD patient outcomes.